Skip to main content
. 2018 Jan 12;91(1084):20170705. doi: 10.1259/bjr.20170705

Table 2.

ADC values regarding other prognostic factors

N ADC values (×10−3) p
Tumour type
 IDC 48 0.988 (0.108–1.520) 0.867
 ILC 6 1.081 (0.155–1.300)
 Other 7 0.874 (0.686–1.630)
Tumour grade
 Grade 1 7 1.190 (0.108–1.630) 0.485
 Grade 2 21 1.020 (0.155–1.410)
 Grade 3 28 0.979 (0.108–1.630)
Ki-67
 Negative 22 1.045 (0.108–1.630) 0.080
 Positive 39 0.965 (0.569–1.520)
Oestrogen receptors
 Negative 11 0.970 (0.108–1.430) 0.632
 Positive 50 0.993 (0.155–1.630)
Progesterone receptors
 Negative 18 0.968 (0.108–1.630) 0.658
 Positive 43 1.010 (0.155–1.520)
C-erb B2
 0 35 1.020 (0.108–1.630) 0.859
 1 9 0.940 (0.874–1.290)
 2 3 0.850 (0.834–1.090)
 3 14 0.980 (0.569–1.520)
Lymphovascular Invasion
 Negative 40 1.001 (0.155–1.630) 0.154
 Positive 21 0.951 (0.108–1.360)
Component
 Absent 16 0.893 (0.108–1.630) 0.187
 DCIS 37 0.993 (0.569–1.520)
 LCIS 8 1.040 (0.155–1.300)

ADC values given as median (minimum–maximum). ADC, apparent diffusion coefficient; DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma